首页> 外文期刊>Medicinal Chemistry >Development and Validation of RP-HPLC-DAD Method to QuantifyHydroxytyrosol Content in a Semi-Solid Pharmaceutical Formulation
【24h】

Development and Validation of RP-HPLC-DAD Method to QuantifyHydroxytyrosol Content in a Semi-Solid Pharmaceutical Formulation

机译:RP-HPLC-DAD法开发和验证半固体药物制剂中羟基酪醇含量的方法

获取原文
           

摘要

Many substances of natural origin are contained in pharmaceutical and cosmetic formulations, but lately extra virgin olive oil (EVOO) or EVOO-derived compounds like tyrosol, hydroxytyrosol or oleuropein, thanks to their renowned and long-established outstanding therapeutic and health giving virtues, have made them some of the most interesting products in this field. Nowadays many hydroxytyrosol-based topical formulations are commercialized and over time several analytical methods have been developed. However, new cosmetic formulations containing an olive extract tritated in hydroxytyrosol conveyed in EVOO have recently appeared on the market creating the need to develop and validate a new method that allows the active compound to be extracted and analyzed precluding any interference due to the presence of other compounds naturally present in the EVOO as well as from the co-formulant agents employed, and this has been the goal of our study. Analytical determination was performed by RP-HPLC coupled with DAD detection. Various chromatographic parameters, namely column stationary phase, mobile phase, pH and solvent composition, oven temperature and different clean-up variables were studied. The best chromatographic separation was obtained under the following conditions: a reverse phase C18 column maintained at 25°C with a gradient elution program using acetic acid 0.2% and methanol as mobile phase pumped at 1.5 mL min?1. Detection wavelength was set at 280 nm and the total run time required was 15 min. The high degree of accuracy (98.8%-100.1%) and precision (1.44%-1.68%) achieved using the evaluated method along with the low limits of detection and quantification (2.49 ppm and 3.97 ppm respectively) and the broad linear range observed allowed the target analyte to be satisfactorily determined in new semi-solid formulation containing hydroxytyrosol conveyed in EVOO while avoiding any matrix effect.
机译:许多天然来源的物质都包含在药物和化妆品制剂中,但是最近由于特级初榨橄榄油(EVOO)或EVOO衍生的化合物,例如酪醇,羟基酪醇或橄榄苦苷,得益于其久负盛名的卓越治疗和保健功能,它们具有使他们成为该领域最有趣的产品。如今,许多基于羟基酪醇的局部制剂已经商品化,并且随着时间的流逝,已经开发了几种分析方法。但是,最近在市场上出现了新化妆品配方,其中含有在EVOO中运送的在羟基酪醇中tri化的橄榄提取物,这需要开发和验证一种新方法,该方法允许提取和分析活性化合物,以排除由于存在其他化合物而造成的任何干扰。 EVOO中天然存在的化合物以及所用的共配方剂中存在的化合物,这一直是我们研究的目标。通过RP-HPLC结合DAD检测进行分析测定。研究了各种色谱参数,即色谱柱固定相,流动相,pH和溶剂组成,柱温箱温度以及不同的净化变量。在以下条件下可获得最佳的色谱分离效果:反相C18柱保持在25°C,采用梯度洗脱程序,使用0.2%的乙酸和甲醇作为流动相,在1.5 mL min-1下泵送。检测波长设置为280 nm,所需的总运行时间为15分钟。使用评估的方法可实现较高的准确度(98.8%-100.1%)和精密度(1.44%-1.68%)以及较低的检测和定量下限(分别为2.49 ppm和3.97 ppm)和观察到的宽线性范围可以在EVOO中输送的含有羟基酪醇的新型半固体制剂中令人满意地测定目标分析物,同时避免任何基质效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号